Net Cash Provided by (Used in) Operating Activities |
52.9M |
USD |
|
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
234M |
USD |
+152% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-295M |
USD |
-250% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
400K |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
400K |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
5 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-7.91M |
USD |
+22% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
131M |
USD |
-40% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Gross |
165M |
USD |
+117% |
Q4 2024 |
FY 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
49.7M |
USD |
|
Q2 2025 |
Q2 2025 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2024 |
FY 2024 |